Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 AUD | -3.51% | 0.00% | -43.30% |
05/04 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
26/02 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-43.30% | 3.43Cr | |
+8.29% | 11TCr | |
+10.21% | 10TCr | |
-11.90% | 2.24TCr | |
+0.26% | 2.23TCr | |
-5.57% | 1.91TCr | |
-37.36% | 1.8TCr | |
-5.17% | 1.79TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Begins Phase Two COVID-19 Trial for Antiviral Medication